The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
Live Science on MSN8h
Ozempic-style drugs tied to more than 60 health benefits and risks in biggest study-of-its-kindA large new study has shed light on the wider health impacts of taking Ozempic-style drugs. Weight-loss drugs like Ozempic ...
The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a study ...
An observational study has uncovered a possible link between taking GLP-1s and increased risk of kidney, pancreas and gut ...
This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...
Researchers from the Washington University School of Medicine looked at the health outcomes among more than two million people taking the popular weight-loss medications.
Researchers have found links to multiple new benefits – and new side effects – in a study of weight-loss drugs such as ...
Weight loss drugs like Ozempic have taken Hollywood by storm.But are there any known side effects known about the new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback